In brief

The Board of Directors has an overview of the Agency’s activities. It makes decisions about the general guidelines, the budget and the accounts while ensuring that the allocated resources are used transparently and effectively. Made up of 37 members appointed by ministerial decree for a term of three years, it includes representatives of the State, health and research agencies and health insurance companies, as well as qualified individuals and employee representatives. The Chair of the Board of Directors is appointed by decree of the President of the Republic for a term of three years.

The Advisory Board ensures that medical and scientific expert assessments are of a high quality by ensuring that practices and innovations comply with ethical rules and users’ rights. The Advisory Board has 31 members who represent the political sphere, the scientific world, the humanities and social sciences, and associations, thereby ensuring a diversified and balanced approach. Issues may be referred to it by the agency’s Chief Executive Officer or it may consider any issues it deems relevant. Its members are appointed by the ministers responsible for health and research for a term of three years.

The Medical and Scientific Committee coordinates the agency’s work from a scientific perspective. Made up of 58 experts divided into two specialist colleges – “transplant” and “human reproduction, embryology and genetics” – it issues opinions that guide the agency’s actions. The members, appointed by the Chief Executive Officer, meet four times a year to assess research projects and evaluate the results of the working groups. The positioning of this committee under the Chief Executive Officer means that scientific recommendations are given optimal consideration in strategic decisions.